Helius Medical Technologies to Release Fourth Quarter and Fiscal Year 2020 Financial Results on March 10, 2021
NEWTOWN, Pa., Feb. 02, 2021 (GLOBE NEWSWIRE) Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that fourth quarter and fiscal year 2020 financial results will be released after the market closes on Wednesday, March 10th.
Management will host a conference call at 5:00 p.m. Eastern Time on March 10th to discuss the results of the quarter and fiscal year. Those who would like to participate may dial 877-407-2988 (201-389-0923 for international callers) and provide access code 13715793. A live webcast of the call will also be provided on the Events section of the Company’s investor relations website and can be accessed directly via the following link: https://78449.themediaframe.com/dataconf/productusers/hls/mediaframe/43341/indexl.html.
Home / Top News / Helius Medical Technologies, Inc. Comments on the Centers for Medicare & Medicaid Services’ Announcement Regarding New Medicare Coverage Pathway for Breakthrough Medical Devices
Helius Medical Technologies, Inc. Comments on the Centers for Medicare & Medicaid Services’ Announcement Regarding New Medicare Coverage Pathway for Breakthrough Medical Devices
NEWTOWN, Pa., Jan. 20, 2021 (GLOBE NEWSWIRE) Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today provided comments in response to a press release issued by the Centers for Medicare & Medicaid Services (“CMS”) on Tuesday, January 12, 2021.
In the press release, CMS stated that it is finalizing a new Medicare coverage pathway, Medicare Coverage of Innovative Technology, or “MCIT,” for Food and Drug Administration (“FDA”)-designated breakthrough medical devices. The MCIT rule will provide national
Helius Medical Technologies, Inc. to Present at the Noble Capital Markets 17th Annual Small & Microcap Investor Conference Helius Medical Technologies, Inc. Newtown, Pennsylvania, UNITED STATES
NEWTOWN, Pa., Jan. 15, 2021 (GLOBE NEWSWIRE) Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that management will participate in the Noble Capital Markets 17th Annual Small & Microcap Investor Conference, which is being held virtually from January 19th-20th. Management will present on Tuesday, January 19th at 11:15 a.m. Eastern Time.
A live audio webcast of the conference presentation will be available on the Noble conference website following free registration: https://www.nobleconference.com/register/investor-guest. An archive of the webcast will be available following the conference under the ‘Events’ section of the Helius Medical Technol